Last reviewed · How we verify

NCT03471299

Association of Survival in Impact of Ultrafiltration Rates in Hemodialysis Patients

Completed Last updated 20 March 2018
What this trial tests

trial in Hemodialysis in 759 participants. Completed in 1 March 2018.

Timeline
1 April 2017
Primary endpoint
1 February 2018
1 March 2018

Quick facts

Lead sponsorUniversity of Hyogo
StatusCompleted
Study typeOBSERVATIONAL
Enrollment759
Start date1 April 2017
Primary completion1 February 2018
Estimated completion1 March 2018
Sites1 location across Japan

Conditions studied

Sponsor

University of Hyogo

Who can join

Eligibility, any sex, with Hemodialysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study assesses retrospectively the association of mortality on UFR assessments in our study population undergoing HD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hemodialysis

Currently open trials in the same condition.

Other University of Hyogo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03471299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing